Add to Favourites
To login click here
This article discusses considerations for determining inventorship in light of technological advancements, specifically in the use of artificial intelligence (AI) systems. It highlights a recent study that used machine learning to detect biomarkers for cancer and the increasing use of AI in the pharmaceutical industry.
